NCT04991324View on ClinicalTrials.gov

Cholecalciferol Comedication in IBD - the 5C-study

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

September 15, 2024

Study Completion Date

September 15, 2024

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG

Vitamin D3

24,000 IU cholecalciferol

Trial Locations (1)

4031

Clarunis, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER